Saturday 25 September 2010

Parkemed




Parkemed may be available in the countries listed below.


Ingredient matches for Parkemed



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Parkemed in the following countries:


  • Austria

International Drug Name Search

Thursday 23 September 2010

Gemicin




Gemicin may be available in the countries listed below.


Ingredient matches for Gemicin



Gentamicin

Gentamicin is reported as an ingredient of Gemicin in the following countries:


  • Peru

International Drug Name Search

Wednesday 22 September 2010

Furosemide Zhaohui Pharm




Furosemide Zhaohui Pharm may be available in the countries listed below.


Ingredient matches for Furosemide Zhaohui Pharm



Furosemide

Furosemide is reported as an ingredient of Furosemide Zhaohui Pharm in the following countries:


  • China

International Drug Name Search

Sunday 19 September 2010

Selovin




Selovin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Selovin



Selenium

Selenium is reported as an ingredient of Selovin in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Saturday 18 September 2010

Ofloxacin Consilient




Ofloxacin Consilient may be available in the countries listed below.


Ingredient matches for Ofloxacin Consilient



Ofloxacin

Ofloxacin is reported as an ingredient of Ofloxacin Consilient in the following countries:


  • Denmark

International Drug Name Search

Friday 17 September 2010

Paroxétine Sandoz




Paroxétine Sandoz may be available in the countries listed below.


Ingredient matches for Paroxétine Sandoz



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxétine Sandoz in the following countries:


  • France

International Drug Name Search

Tuesday 14 September 2010

Ondansetron Orally Disintegrating Tablets


Pronunciation: on-DAN-se-tron
Generic Name: Ondansetron
Brand Name: Zofran ODT


Ondansetron Orally Disintegrating Tablets are used for:

Preventing nausea and vomiting associated with chemotherapy, radiation treatment, or surgery. It may also be used for other conditions as determined by your doctor.


Ondansetron Orally Disintegrating Tablets are a serotonin 5-HT3 receptor blocker. It works by blocking a chemical thought to be a cause of nausea and vomiting in certain situations (eg, chemotherapy).


Do NOT use Ondansetron Orally Disintegrating Tablets if:


  • you are allergic to any ingredient in Ondansetron Orally Disintegrating Tablets

  • you are taking apomorphine

  • you have a certain type of irregular heartbeat (congenital long QT syndrome)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ondansetron Orally Disintegrating Tablets:


Some medical conditions may interact with Ondansetron Orally Disintegrating Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have had an allergic reaction to another serotonin 5-HT3 receptor blocker (eg, dolasetron, granisetron)

  • if you have liver problems, heart problems (eg, congestive heart failure, slow or irregular heartbeat, QT prolongation), or electrolyte problems (eg, low potassium or magnesium levels), or phenylketonuria (PKU)

  • if you take medicines that may affect your heartbeat. Check with your doctor if you are unsure if any of your medicines may affect your heartbeat

Some MEDICINES MAY INTERACT with Ondansetron Orally Disintegrating Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Apomorphine because the risk of its side effects may be increased by Ondansetron Orally Disintegrating Tablets.

  • Antineoplastic agents (eg, cyclophosphamide) or tramadol because their effectiveness may be decreased by Ondansetron Orally Disintegrating Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ondansetron Orally Disintegrating Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ondansetron Orally Disintegrating Tablets:


Use Ondansetron Orally Disintegrating Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Ondansetron Orally Disintegrating Tablets by mouth with or without food or water.

  • Do not remove the tablet from the blister pack until you are ready to take Ondansetron Orally Disintegrating Tablets. Make sure that your hands are dry when you open the blister pack. Do not push the tablet through the foil. Peel back the foil on the blister pack and place the tablet on your tongue. The tablet dissolves quickly and can be swallowed with saliva. Ondansetron Orally Disintegrating Tablets may be taken with or without water. Take the tablet immediately after opening the blister pack. Do not store the removed tablet for future use.

  • To prevent or reduce the possibility of nausea or vomiting, continue taking Ondansetron Orally Disintegrating Tablets for the entire time recommended by your doctor even if you do not notice any nausea.

  • If you miss a dose of Ondansetron Orally Disintegrating Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ondansetron Orally Disintegrating Tablets.



Important safety information:


  • Ondansetron Orally Disintegrating Tablets may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Ondansetron Orally Disintegrating Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.

  • Ondansetron Orally Disintegrating Tablets should be used with extreme caution in CHILDREN younger than 4 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ondansetron Orally Disintegrating Tablets while you are pregnant. It is not known if Ondansetron Orally Disintegrating Tablets are found in breast milk. If you are or will be breast-feeding while you use Ondansetron Orally Disintegrating Tablets, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Ondansetron Orally Disintegrating Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; headache; tiredness; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; wheezing; unusual hoarseness); chest or jaw pain, numbness of an arm or leg, or sudden severe headache or vomiting; fainting; fast, slow, or irregular heartbeat; fever; seizures; severe or persistent dizziness; skin tingling or numbness; stomach pain; trouble urinating; uncontrolled muscle movements; vision changes or loss.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Ondansetron side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; severe dizziness; slowed, irregular heartbeat; sudden, temporary blindness.


Proper storage of Ondansetron Orally Disintegrating Tablets:

Store Ondansetron Orally Disintegrating Tablets between 36 and 86 degrees F (2 and 30 degrees C) in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ondansetron Orally Disintegrating Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Ondansetron Orally Disintegrating Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Ondansetron Orally Disintegrating Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ondansetron Orally Disintegrating Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ondansetron resources


  • Ondansetron Side Effects (in more detail)
  • Ondansetron Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ondansetron Drug Interactions
  • Ondansetron Support Group
  • 81 Reviews for Ondansetron - Add your own review/rating


Compare Ondansetron with other medications


  • Alcohol Dependence
  • Gastroenteritis
  • Nausea/Vomiting
  • Nausea/Vomiting, Chemotherapy Induced
  • Nausea/Vomiting, Postoperative
  • Nausea/Vomiting, Radiation Induced
  • Obsessive Compulsive Disorder
  • Postanesthetic Shivering
  • Pruritus

Sunday 12 September 2010

Fluxum




Fluxum may be available in the countries listed below.


Ingredient matches for Fluxum



Parnaparin Sodium

Parnaparin Sodium is reported as an ingredient of Fluxum in the following countries:


  • Hungary

  • Italy

  • Mexico

  • Poland

  • Turkey

International Drug Name Search

Thursday 9 September 2010

Hexaniton




Hexaniton may be available in the countries listed below.


Ingredient matches for Hexaniton



Inositol Nicotinate

Inositol Nicotinate is reported as an ingredient of Hexaniton in the following countries:


  • Greece

International Drug Name Search

Cifespasmo




Cifespasmo may be available in the countries listed below.


Ingredient matches for Cifespasmo



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Cifespasmo in the following countries:


  • Argentina

International Drug Name Search